ALFA Finder| Revenue growth | 20% YoY for FY26; 23% YoY for Q4. |
|---|---|
| Margins | Gross margin expanded 355bps to 65% due to product mix shift. |
| Order book | Not disclosed for Senn; demand-linked capex approach. |
| Demand visibility | Strong traction in Europe (81% growth) and North America formulations. |
| Management confidence | High on peptide CDMO and U.S. generic market positioning. |
Growth
FY26 Revenue grew 20% to INR 5,366 Cr; PAT reached INR 595 Cr, up 19% YoY.
Outlook
Guided for INR 600 Cr capex in FY27; focus on U.S. product launches and scaling peptide CDMO.
Risks
Regulatory remediation at Gagillapur continues; external cost pressures and freight volatility remain uncertain.
Earnings Call filed with NSE, NSE: GRANULES. Summary written with AI assistance from the document.
Granules India Ltd: key numbers
- Share price
- ₹799.25
- Market cap
- ₹19,805 Cr
- Revenue (annual)
- ₹5,366 Cr
- Net profit (annual)
- ₹595.0 Cr
- P/E (TTM)
- 27.8×Sector 43.8×
- Promoter holding
- 37.39%-0.63% QoQ
- FII holding
- 20.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Granules India Ltd
All →Granules India Earnings Call Transcript: Key Takeaways
Q2 revenue ₹1,560 Cr (+20% YoY) and PAT ₹182 Cr (+39%), but EBITDA margin fell 131bps QoQ on West Asia costs. Gagilapur FDA observations leave the warning letter unresolved.
Granules India Other Announcement
Granules India submitted its monitoring agency report on preferential issue proceeds for quarter ended September 2026. It reports no deviation from stated objects.
Granules India Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹15,600 Mn (+20% YoY), EBITDA ₹3,376 Mn (21.6% margin), PAT ₹1,818 Mn (+39%). Net cash ₹8,280 Mn after warrant proceeds.
Granules India Results Update
Granules India reported Q2FY27 revenue of INR 15,600 Mn, up 20% YoY, and PAT of INR 1,818 Mn, up 39%. The company also cited a net cash position and a US FDA audit at its Gagillapur site.
Granules India Q2 FY27 Results: Net Profit ₹181.8 Cr, Up 39.2% YoY
Granules India Ltd reported revenue from operations of ₹1,560 Cr (+20.3% YoY) and net profit of ₹181.8 Cr (+39.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹181.8 Cr · +39.2% YoY
Granules India Business Update
Granules' Gagillapur facility received eleven USFDA observations with no impact on product supply. The inspection was the first since a February 2025 Warning Letter.